314 related articles for article (PubMed ID: 6774690)
1. [Basic requirements of viral vaccines and methods for their control].
Osidse DF
Arch Exp Veterinarmed; 1980; 34(1):123-6. PubMed ID: 6774690
[TBL] [Abstract][Full Text] [Related]
2. Live virus vaccines for use in animals.
Bostock CJ
Dev Biol Stand; 1995; 84():41-8. PubMed ID: 7796966
[No Abstract] [Full Text] [Related]
3. Viral oncogenicity and viral vaccines--general comments.
Gerber P
Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932
[No Abstract] [Full Text] [Related]
4. Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney.
Doll ER; Bryans JT; Wilson JC; McCollum WH
Cornell Vet; 1968 Oct; 48(4):497-524. PubMed ID: 4971878
[No Abstract] [Full Text] [Related]
5. Technology of production of primary and diploid cell cultures.
Brackett RG
Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
[No Abstract] [Full Text] [Related]
6. Tissue culture of viruses (author's transl).
Can J Med Technol; 1974 Jun; 36(3):231 passim. PubMed ID: 4368290
[No Abstract] [Full Text] [Related]
7. Production of viral vaccines for veterinary use.
van Gelder P; Makoschey B
Berl Munch Tierarztl Wochenschr; 2012; 125(3-4):103-9. PubMed ID: 22515027
[TBL] [Abstract][Full Text] [Related]
8. Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges.
Delrue I; Verzele D; Madder A; Nauwynck HJ
Expert Rev Vaccines; 2012 Jun; 11(6):695-719. PubMed ID: 22873127
[TBL] [Abstract][Full Text] [Related]
9. Viral oncogenicity and virus vaccines--summary.
Habel K; Murphy WH
Natl Cancer Inst Monogr; 1968 Dec; 29():561-3. PubMed ID: 5713331
[No Abstract] [Full Text] [Related]
10. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Fellowes ON
Natl Cancer Inst Monogr; 1968 Dec; 29():209-14. PubMed ID: 5720794
[No Abstract] [Full Text] [Related]
11. Characteristics of cell culture systems. Viral flora of canine tissues.
Gillespie JH
Natl Cancer Inst Monogr; 1968 Dec; 29():133-9. PubMed ID: 4305426
[No Abstract] [Full Text] [Related]
12. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Jensen KE
Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793
[No Abstract] [Full Text] [Related]
13. Clinical experience with vaccines produced in the human diploid cell line WI-38.
Andzaparidze OG
Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
[No Abstract] [Full Text] [Related]
14. Cell cultures for virus vaccine production. General conclusions from the conference.
Merchant DJ
Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811
[No Abstract] [Full Text] [Related]
15. Latent viral infections in donor tissues and in recipients of vaccines.
Melnick JL
Natl Cancer Inst Monogr; 1968 Dec; 29():337-49. PubMed ID: 4305432
[No Abstract] [Full Text] [Related]
16. Characteristics of cell culture systems: viral flora of tissue sources and tissue and medium antigens in vaccines--summary.
Sigel MM; von Magnus H
Natl Cancer Inst Monogr; 1968 Dec; 29():551-4. PubMed ID: 4976867
[No Abstract] [Full Text] [Related]
17. Vaccines against dengue virus.
Woodland DL
Viral Immunol; 2015 Mar; 28(2):75. PubMed ID: 25689610
[No Abstract] [Full Text] [Related]
18. Vaccines produced in heteroploid cell lines--discussion.
Hull RN
Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
[No Abstract] [Full Text] [Related]
19. Authorisation within the European Union of vaccines against antigenically variable viruses responsible for major epizootic diseases.
Mackay DK
Rev Sci Tech; 2007 Aug; 26(2):421-8. PubMed ID: 17892162
[TBL] [Abstract][Full Text] [Related]
20. [Immunity of viruses and the effectiveness of vaccines. Mode of virus infections and effectiveness of vaccines].
Shishido A
Nihon Rinsho; 1987 Oct; 45(10):2218-24. PubMed ID: 3448260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
